Medis Methodology Statement

Introduction

This Methodology Statement defines the relevant types of transfers to be disclosed, which transfers are excluded, and other relevant information to assist the reader to understand how Medis’ collected, organised and reported the disclosed data.
 

Scope of Disclosure

Medis discloses the ToV to HCPs,  HCOs and PAGs in countries where Medis operates and has a presence through an affiliate.

The disclosure is made in aggregate form.

Products covered

Prescription drugs, OTC drugs, food supplements and other healthcare products, medical devices.

Types of transfers of value

ToVs that are disclosed:

  • Donations and grants to HCOs and PAGs
  • Sponsorship agreements with HCOs / third parties contracted by HCOs to run an event
  • Registration fees
  • Travel and lodging expenses
  • Fees for services

Donation and Grants to HCO’s

Donations and Grants to HCO’s that support healthcare including donations, grants and benefits in kind to institutions, organizations or associations that are comprised of HCP’s and/or that provide healthcare.

Congress Sponsorship

These are events organized by third parties like medical societies, academic institutions, or professional conference organizers. Medis can participate in these events through:

  • sponsorship (e.g., exhibition booths, satellite symposia, advertisements) or
  • by sponsoring participants to attend (registration fee, Travel & Accommodation)

Fee for service

An FMV based payment to an individual HCP for a specific service provided to Medis. Fee for service arrangements including, but not limited to:

  • Speaking engagements at scientific, educational, or promotional events

organised by third parties or Medis

  • Consulting engagements such as participation on advisory boards, preparation

of written or audio/video educational materials, publications, disease management procedures, and software.

  • Workshops organised by third parties or Medis
  • Market research, which should be conducted in collaboration with third-party

vendors experienced in the field, as appropriate.

PO (Patient Organization)

Any non-for-profit legal person or entity, mainly composed of patients and/or caregivers, who represent and/or supports the needs of patients and/or caregivers.

Disclosure must include a total amount paid, monetary value or non- monetary benefit.

ToV timeframe

Medis discloses ToVs made during the reporting year.

ToV Recognition Date

ToVs are disclosed on the basis of the date Medis made the ToV, not when the resulting income or benefit was received by the HCO/HCP. Indirect ToVs concerning travel and accommodation are disclosed on the basis of the date that the event took place; Direct ToVs are disclosed on the basis of the date the ToV is posted to our finance systems.

Direct and Indirect ToV

ToV can be made directly to the HCP or HCO, such as service fee to the HCP for giving a lecture.

ToV can be made indirectly to the HCP or HCO, such as accommodation costs paid to an agency on behalf of an HCP.

Self-established HCPs

TOVs to self-established HCPs are disclosed ToVs to HCPs to the extent possible.
 

Disclosure format and platform

Disclosure reports are published on the Medis corporate website within six months of the reporting year for all countries in which Medis operates. The information disclosed shall remain available for three (3) years thereafter.

The reports are disclosed in English.
 

Disclosure of financial data

Currency: All disclosed ToVs are reported in local currency. ToVs paid in other currencies are converted to local currency at the exchange rate applicable on the date the cost is incurred.

TAX: Disclosed ToV’s to HCO’s and HCP’s reflect the amounts agreed in the contracts and on invoices submitted to Medis by HCO’s or HCP’s. The data collection and reporting is based on “net amounts” exclusive of VAT, and in cases where Medis pays taxes and social security contributions on behalf and for the account of HCPs, also net of such taxes and contributions. If VAT cannot accurately be excluded, as in the case of travel and accommodation costs, the full ToV amount is disclosed exceptionally.